FDA Warns Empower Pharmacy Over Mass Copying Of GLP-1 Drugs
7d
1
The Food and Drug Administration on Sept. 18 issued a warning letter to Empower Pharmacy over its compounding of GLP-1 drugs, escalating a fight over whether compounding has become illegal mass production. CBS News